Efficacy of Glimepiride in Patients with Poorly Controlled Insulin-treated Type 2 Diabetes Mellitus-Reference-Cited by-同舟云学术

Efficacy of Glimepiride in Patients with Poorly Controlled Insulin-treated Type 2 Diabetes Mellitus

Published:2005 Issue:5 Volume:52 Page:563-569
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

OSE Hiroyuki¹,FUKUI Michiaki¹,KITAGAWA Yoshihiro²,HIRATA Chizuko²,ICHIO Naoko²,KADONO Mayuko¹,MOGAMI Shin-ichi¹,ONISHI Masayoshi¹,ICHIDA Yukiko¹,NAKAJIMA Toshiki¹,HASEGAWA Goji¹,YOSHIKAWA Toshikazu³,NAKAMURA Naoto¹

Affiliation:

1. Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science

2. Department of Endocrinology and Hematology, Osaka General Hospital of West Japan Railway Company

3. Department of Inflammation and Immunology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.jstage.jst.go.jp/article/endocrj/52/5/52_5_563/_pdf

Reference34 articles.

1. INCREASED INSULIN SENSITIVITY AND CELLULAR INSULIN BINDING IN OBESE DIABETICS FOLLOWING TREATMENT WITH GLIBENCLAMIDE

2. Appraisal of the Extrapancreatic Actions of Sulfonylureas

3. Atherogenicity of insulin

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits and risks of drug combination therapy for diabetes mellitus and its complications: a comprehensive review;Frontiers in Endocrinology;2023-12-19

2. Clinical Evidence and Practice-Based Guidelines on the Utility of Basal Insulin Combined Oral Therapy (Metformin and Glimepiride) in the Current Era;Current Diabetes Reviews;2023-10

3. The Influence of Sitagliptin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Prespecified Sub-Analysis;Diabetes Therapy;2017-05-17

4. Insulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control;Cochrane Database of Systematic Reviews;2016-09-18

5. Adding glimepiride to current insulin therapy increases high-molecular weight adiponectin levels to improve glycemic control in poorly controlled type 2 diabetes;Diabetology & Metabolic Syndrome;2014-03-20